ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
LendingTree Inc

LendingTree Inc (T77)

39.50
-1.33
(-3.26%)
Cerrado 25 Enero 3:00PM
Realtime Data

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
39.50
Postura de Compra
39.28
Postura de Venta
39.69
Volume Operado de la Acción
10
39.56 Rango del Día 39.56
27.00 Rango de 52 semanas 57.50
Capitalización de Mercado [m]
Precio Anterior
40.83
Precio de Apertura
39.56
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
229
Acciones en circulación
13,362,034
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.52
Beneficio por acción (BPA)
-9.16
turnover
672.5M
Beneficio neto
-122.4M

Acerca de LendingTree Inc

Sector
Loan Brokers
Industria
Loan Brokers
Sede
Charlotte, North Carolina, USA
Fundado
-
LendingTree Inc is listed in the Loan Brokers sector of the Tradegate (DE) with ticker T77. The last closing price for LendingTree was 40.83 €. Over the last year, LendingTree shares have traded in a share price range of 27.00 € to 57.50 €.

LendingTree currently has 13,362,034 shares in issue. The market capitalisation of LendingTree is 545.57 € million. LendingTree has a price to earnings ratio (PE ratio) of -4.52.

T77 Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.06-0.15166835187139.5643.1339.5621442.60104215DE
42.145.7280513918637.3643.1334.8616139.61829859DE
12-15.06-27.602639296254.5655.8834.3922942.48842833DE
26-12.1-23.449612403151.657.534.3918945.28921054DE
5210.536.20689655172957.52722441.35204704DE
156-72.5-64.7321428571112113.6510.69999918335.15023287DE
260-216.6-84.5763373682256.1292.410.69999911838.79385824DE

T77 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de LendingTree?
El precio actual de las acciones de LendingTree es 39.50 €
¿Cuántas acciones de LendingTree están en circulación?
LendingTree tiene 13,362,034 acciones en circulación
¿Cuál es la capitalización de mercado de LendingTree?
La capitalización de mercado de LendingTree es EUR 545.57M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de LendingTree?
LendingTree ha negociado en un rango de 27.00 € a 57.50 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de LendingTree?
El ratio precio/beneficio de LendingTree es -4.52
¿Cuál es el ratio de efectivo a ventas de LendingTree?
El ratio de efectivo a ventas de LendingTree es 0.82
¿Cuál es la moneda de reporte de LendingTree?
LendingTree presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de LendingTree?
El último ingresos anual de LendingTree es USD 672.5M
¿Cuál es el último beneficio anual de LendingTree?
El último beneficio anual de LendingTree es USD -122.4M
¿Cuál es la dirección registrada de LendingTree?
La dirección registrada de LendingTree es 11115 RUSHMORE DRIVE, CHARLOTTE, NORTH CAROLINA
¿Cuál es la dirección del sitio web de LendingTree?
La dirección del sitio web de LendingTree es www.lendingtree.com
¿En qué sector industrial opera LendingTree?
LendingTree opera en el sector LOAN BROKERS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
LL3PanGenomic Health Inc
0.2999 €
(67.26%)
2.89k
VAR1Varta AG
1.00 €
(37.93%)
3.62M
FP9Five Point Holdings LLC
5.35 €
(36.48%)
20
UD9Mason Resources Inc
0.0616 €
(36.28%)
28k
8CTCannabix Technologies Inc
0.32 €
(33.33%)
250
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
34.02k
POTAPortofino Resources Inc
0.0032 €
(-38.46%)
150k
G12Global Atomic Corp
0.425 €
(-31.95%)
729.18k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-30.00%)
139.6k
PF8European Lithium Limited
0.0348 €
(-3.33%)
9.79M
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
D7GNel ASA
0.1932 €
(0.99%)
4.13M
0QJHexagon Purus ASA
0.2725 €
(-22.59%)
3.99M
VAR1Varta AG
1.00 €
(37.93%)
3.62M
oldmystic oldmystic 4 minutos hace
I think it is very cool and like it, just not convinced of the value. In corporate life we spent a fair amount of effort on charting software and did extensive studies on TA to determine how much Alfa if any it can provide. The results were not overwhelming, which of course doesn't they can't be for
AVXL
TAB78 TAB78 4 minutos hace
I have this a few times, I take it mean company wants us to know what the AS & OS is

I called OTC once and asked about why its updated daily on some, they said it depends on the arrangement between the company and their TA

Since the TA is the one that reports it to OTC
GRLF
Zorax Zorax 4 minutos hace
We were already dealing with the highest assault of bird flu ever which was already raising prices.

And with rfk in the health spot, he'll not allow vaccines or studies and wait 5 years for everyone to get sick and die from bird flu because of his belief of a defunct and debunked deca
k9narc k9narc 4 minutos hace
I prefer my kale

With a silent K
CanItBThisEZ2Make CanItBThisEZ2Make 5 minutos hace
Thank You, Very Much, That's a straight up $0.43 per share by rough calculations IMO - NFA!

GO $AZRH
AZRH
Invest-in-America Invest-in-America 5 minutos hace
TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN ; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called ' NEWS ' with terms like ' partnering with', or ' tea
TVGN
capgain capgain 5 minutos hace
Tele's and Lucinda, how can you go wrong? :)
KILLAZILLA KILLAZILLA 6 minutos hace
F- CREDIT RATING AND NO POSITIVE INCOME ARE 2 OTHERS....

SHOULD I LIST MORE???

MAMALUKE!!!
WDLF
declaes declaes 6 minutos hace
25,000,000 revenues in 2025!!!

style="font-size: 16px"Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
GRST
wiwineguy wiwineguy 7 minutos hace
Looks great Mr Chen!  Thank you
TGLO
double_m double_m 7 minutos hace
Real funny when the dreamers show up on this board with posts showing optimism for $MULN. These guys refuse to believe any warnings about this company and its 💩CEO. Most of us have been dealing with Mullen for as much as 3 years and have lost varying amounts of money to the blatant lies and
MULN
ThunderousSeer8 ThunderousSeer8 7 minutos hace
It is tiring even for me seeing him exhausting himself in desperation
RDAR
justhefax justhefax 11 minutos hace
i share the desire for success as i do have a significant stake.
Apart from Schwab i don't see any visible sign of the name change. If any see other places good to know.

I dont see the work you refer to apart from releases going back to spring ( and Schwab). The name change was
KGKG
IhidfromtheX IhidfromtheX 11 minutos hace
Time diagnosed until the average life span for an illness IMO is a great marker...The longer the better...
AVXL
zab zab 12 minutos hace
I have noticed that also, did you see this article.

https://www.seattletimes.com/nation-world/nation/more-dei-fallout-air-force-scraps-course-that-used-videos-of-tuskegee-airmen-and-female-wwii-pilots/

https://www.detroitnews.com/story/news/politics/2025/01/25/air-force
exwannabe exwannabe 13 minutos hace
I think TVO gave end of February as a grace period for some time. Unlike many, he’s willing to say if it goes beyond that, his concern level would increase. Right now, he’s still expecting January (with February as the final grace period). IMO. I pretty much echo his sentiment, based upon his and ly
NWBO
Johnniegalan Johnniegalan 14 minutos hace
JR….tell that to the folks with special insight who have fueled a nearly 50% increase in the price of the stock in the last 3 weeks or so..
AMRN
boi568 boi568 15 minutos hace
If dramatic brain preservation is not a validated biomarker for AD because no other effective drug has achieved the most obviously desirable physical result for this disease, then the FDA should use whatever discretion it enjoys to relax the "validated" requirement here.

Otherwise, w
AVXL

Su Consulta Reciente

Delayed Upgrade Clock